Home
Conditions
Pancreatic Adenocarcinoma Metastatic

Clinical trial condition

Pancreatic Adenocarcinoma Metastatic

Explore clinical trials studying Pancreatic Adenocarcinoma Metastatic. Study availability and eligibility vary by location and protocol.

20 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Adenocarcinoma Metastatic trial results

Not Yet Recruiting

A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors

NCT07566897

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations: Fondazione Policlinico Gemelli Unità di Fase 1: Unità di Farmacologia Clinica Roma, Italy

View Trial Details

Not Yet Recruiting

Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.

NCT06615830

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer

NCT07314385

Conditions: Liver Metastasis, Pancreatic Adenocarcinoma Metastatic
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Real World Efficacy, Safety of Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Metastatic Pancreatic Cancer After Previous Gemcitabine-based Therapy

NCT06006728

Conditions: Pancreatic Adenocarcinoma Metastatic
Locations: CHU Bordeaux Pessac, France

View Trial Details

Completed

Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer

NCT01053013

Conditions: Colorectal Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma Non-resectable
Locations: Weill Cornell Medical Center / The Rogosin Institute New York, United States

View Trial Details

Completed

Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer

NCT01715142

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Antwerp University Hospital (UZA) Edegem, Antwerpen, Belgium

Erasme University Hospital (ULB) Brussels, Belgium

View Trial Details

Completed

To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

NCT02179970

Conditions: Adnexal Diseases, Colonic Diseases, Colorectal Cancer Metastatic, +26 more
Locations: Addenbrookes Hospital Cambridge, United Kingdom

View Trial Details

Completed

Scheduling Nab-paclitaxel With Gemcitabine

NCT03529175

Conditions: Pancreatic Adenocarcinoma Metastatic
Locations: Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom

Peterborough City Hospital Peterborough, Cambridgeshire, United Kingdom

Ysbyty Gwynedd Bangor, United Kingdom

Belfast City Hospital Belfast, United Kingdom

View all 23 locations

View Trial Details

Completed

Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

NCT02195180

Conditions: Adenocarcinoma, Carcinoma, Neoplasms, +3 more
Locations: Saint Catherine Institute Avignon, France

Institut de Cancerologie Brest, France

Hopital Beaujon Clichy, France

Hospital Henri Mondor Créteil, France

View all 16 locations

View Trial Details

Active, Not Recruiting

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

NCT05077800

Conditions: Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Massachusetts General Hospital Charlestown, Massachusetts, United States

University of Washington School of Medicine Seattle, Washington, United States

View Trial Details

Pancreatic Adenocarcinoma Metastatic

Pancreatic Adenocarcinoma Metastatic trial results

Related conditions